Purchase of Additional Shares. Praxis shall not purchase any Shares in addition to those to which Praxis is entitled pursuant to Section 6 unless such purchase is made in conjunction with or pursuant to an agreement between Praxis and XXXXXXXXX for the acquisition by Praxis of voting control of XXXXXXXXX.
Purchase of Additional Shares. In the event that the over-allotment option is exercised in full or in part, Subscriber shall purchase up to an additional 52,500 Shares (“Additional Shares”), in the same proportion as the amount of the over-allotment option that is exercised, and simultaneously with such purchase of Additional Shares, as payment in full for the Additional Shares being purchased hereunder, and at least one (1) business day prior to the closing of all or any portion of the over-allotment option, Subscriber shall pay $10.00 per Additional Share, up to an aggregate amount of $525,000, by wire transfer of immediately available funds or by such other method as may be reasonably acceptable to the Company, to be deposited and held in the Company’s segregated trust account (the “Trust Account”).
Purchase of Additional Shares. Investor agrees, for a period of one (1) year from the date of this Agreement, it will not purchase additional shares of the Company without the prior approval of the Company's Board of Directors.
Purchase of Additional Shares. At each Subsequent Closing (as hereinafter defined), the Purchaser shall have the option, in its sole discretion, to purchase a greater number of shares of Stock than that set forth on Exhibit B with respect to the date of such Subsequent Closing (the "Accelerated Amount"). The purchase price for the Accelerated Amount shall be the same as that set forth on Exhibit B for the shares of Stock to be purchased on such Subsequent Closing. If such greater number of shares is purchased, the number of the remaining shares to be purchased at each Subsequent Closing thereafter will be reduced on a pro rata basis, such that the aggregate number of shares of Stock purchased by the Purchaser pursuant to this Agreement is 483,795.
Purchase of Additional Shares. The Subscriber hereby agrees that it will purchase additional shares of Class A Common Stock (“Over-Allotment Shares”), up to a maximum of 30,000 Over-Allotment Shares, for a purchase price of $300,000 per share (“Over-Allotment Share Purchase Price”), so that at least $10.20 per share sold to the public in the IPO is held in the trust account (as described in the Registration Statement, the “Trust Account”) regardless of whether the over-allotment option is exercised in full or in part. The consummation of the purchase and issuance of the Over-Allotment Shares shall occur simultaneously with the closing of any exercise of the over-allotment option related to the Company’s initial public offering. The number of Over-Allotment Shares that Company shall issue and sell to the Subscriber shall the product of (a) thirty thousand (30,000) and (b) the quotient of (1) the number of units of the Company purchased in such over-allotment option exercise divided by (2) one million and five hundred thousand (1,500,000).
Purchase of Additional Shares. (a) Subject to the terms and conditions hereof, upon the Company's receipt from the U.S. Food and Drug Administration (the "FDA") of marketing clearance for the Product (the "Additional Closing Event"), the Company hereby agrees to issue and sell to Purchaser, and Purchaser hereby agrees to purchase from the Company at the Additional Closing (as hereinafter defined), the number of shares of Common Stock (the "Additional Shares") determined by dividing (i) $5,000,000 by (ii) the average closing price of a share of Common Stock as quoted on the Nasdaq National Market (or such other exchange or market on which the Company's Common Stock is then traded) for the sixty consecutive trading days which immediately precede the date of the Additional Closing Event, at such price per share, for an aggregate purchase price for the Additional Shares of $5,000,000 (the "Additional Shares Purchase Price").
Purchase of Additional Shares. The closing of the purchase by ----------------------------- Purchaser of all shares of Ridgewood stock owned by ADT Security Services, Inc. shall have been consummated or shall be consummated simultaneously with the Closing.
Purchase of Additional Shares. On or before the Closing Date, Buyer shall have purchased from stockholders of Company (other than Selling Stockholders) an aggregate of not less than 4,529,789 shares of the capital stock of Company at a purchase price of not more than NT$20.00 per share.
Purchase of Additional Shares. Subject to satisfaction of the conditions precedent set forth in Section 1.1.4, at the Closing, CHH and/or its designee shall pay Clariti the sum of Ten Million Eight Hundred and Fifty Thousand U.S. Dollars (USD $10,850,000), by certified check or wire transfer, in exchange for Clariti's issuance to CHH and/or its designee of Six Million One Hundred and Ninety-Nine Thousand Nine Hundred and Twenty-Nine (6,199,929) shares of Clariti's common stock $.001 par value (the "Additional Clariti Common Stock Sold to Seller").
Purchase of Additional Shares. On or before January 31, 1999, Lockheed will have purchased an additional 1,600,000 shares of Triton Series B Preferred Stock at a purchase price of $2.50 per share. The purchase and sale of such shares shall be accomplished by a Series B Preferred Stock purchase agreement substantially similar to that entered into by Triton and Lockheed on July 31, 1998.
